Washington, D.C., District of Columbia 20010

  • Heart Failure


The purpose of this study is to examine the relative predictive ability of the derived monitoring instrument to determine post discharge instability and 30-day outcomes in patients discharged with HF. The primary hypothesis is that variables in the monitoring instrument, individually and combined, identify risk for 30-day outcomes. Clinical indicators of dyspnea, fatigue, orthopnea, dyspnea with exertion, daily weight, edema, heart rate, blood pressure, mental condition, medication adherence, and overall well-being will be reported by participants on a daily basis and considered indicators for 30-day outcomes of stability, re-hospitalization, or mortality.


Inclusion Criteria: 1. > 65 years of age 2. male and female patients admitted to the hospital with the primary diagnosis of HF with hospitalization > 24 hours 3. able to read and write in English 4. discharged to home environment Exclusion Criteria: 1. a cardiac transplant candidate 2. experienced an acute coronary event within the previous 30 days of index hospitalization 3. experienced percutaneous coronary intervention or coronary artery bypass grafting within the previous 30 days of index hospitalization 4. end stage renal disease/hemodialysis 5. have a left ventricular assist device 6. > 400 lbs 7. unable to stand for 90 seconds independently

Study is Available At:

Original ID:




Secondary ID:

Study Acronym:

Brief Title:

Patient Self Monitoring to Evaluate 30 Day Post Discharge Heart Failure Outcomes

Official Title:

Patient Self Monitoring to Evaluate 30 Day Post Discharge Heart Failure Outcomes

Overall Status:


Study Phase:




Minimum Age:

65 Years

Maximum Age:


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Georgetown University

Oversight Authority:

United States: Institutional Review Board

Reasons Why Stopped:

Study Type:


Study Design:

Number of Arms:


Number of Groups:


Total Enrollment:


Enrollment Type:


Study Dates

Start Date:January 2016
Completion Date:August 30, 2017
Completion Type:Actual
Primary Completion Date:August 2017
Primary Completion Type:Actual
Verification Date:December 2016
Last Changed Date:October 18, 2017
First Received Date:April 14, 2015

Study Outcomes

Outcome Type:Primary Outcome
Measure:Number of participants with adverse events of rehospitalization and/or mortality.
Time Frame:30 days
Safety Issues:False
Description:Trial a novel 30-day post-discharge monitoring instrument after hospitalization for heart to evaluate patient status based on patient self-monitoring.

Study Interventions

Intervention Type:Behavioral

Study Arms

There are no available Study Arms

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:Georgetown University

Samples and Retentions

Study Population: Patients with heart failure
Sample Method:Non-Probability Sample

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

This study is not currently recruiting Study Participants. The form below is not enabled.